Revelation Biosciences Corp (REVB) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Revelation Biosciences immunoterapiya agentlarini ishlab chiqadi, bunda formulaning tasdiqlanishi xomashyo xarajatlarining pastligi bilan bir qatorda ulkan marjalarni ta'minlaydi. GURU.Markets platformasida pul formatida vizuallashtirilgan ushbu bozor tendentsiyasi 0.05 qiymatini ko'rsatmoqda. Biznes patentlar ustidan to'liq nazoratni saqlagan holda, sinovlarni tashqi pudratchilarga topshiradi. Bundan tashqari, Revelation Biosciences tabiiy inson immunitetini rag'batlantirish uchun universitetlar bilan ilmiy ittifoqlar o'rnatmoqda.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_REVB_-_Revelation-Biosciences_-_Long-Term-Debt-to-Capital "REVB: Revelation Biosciences, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
Revelation Biosciences (REVB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Revelation Biosciences|REVB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati revbiosciences.com|REVB - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Revelation Biosciences, Inc.|REVB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Revelation Biosciences|Tezkor likvidlik ko‘rsatkichi revbiosciences.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Revelation Biosciences Inc - REVB
Ushbu koeffitsiyent kompaniyaning o'z kapitaliga nisbatan uzoq muddatli qarz moliyalashtirishga qanchalik bog'liqligini belgilaydi. GURU.Markets platformasida uzoq muddatli qarzning kapitalga nisbati tahlil qilinishi orqali investorlar emitentning uzoq muddatli to'lov qobiliyatini baholaydilar. Ushbu ko'rsatkich bir yildan ortiq muddatga ega majburiyatlarning sof aktiv qiymatiga nisbati sifatida hisoblanadi. Revelation Biosciences uchun ushbu muvozanat juda muhimdir, chunki immunologiya sohasidagi kuchli ilmiy obro'si kompaniyaga qulay shartlar asosida kapital jalb qilish imkonini beradi. Bu yerdagi past qiymatlar kompaniyaning mavqei tez sur'atlar bilan o'sayotgan davrda moliyaviy barqarorlikni tasdiqlaydi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PVLA (Pieris Corp)|SVRA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati rigel.com (RIGL)|Uzoq muddatli qarzning o'z kapitaliga nisbati ANAB|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning kapitalga nisbati ENGN|RAPT - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aerovate Therapeutics JBIO|aclaristx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Kyverna Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|TLSA - Uzoq muddatli qarzning kapitalga nisbati|CABA (Cabaletta Bio, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|VTYX: Uzoq muddatli kreditlarning kapitalga nisbati|THTX (Theratechnologies Inc.) - Uzoq muddatli qarzning kapitalga nisbati|avalotx.com (AVTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Eledon Pharmaceuticals, Inc. (ELDN)|AGEN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio, Inc. CLYM|ZURA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ATYR: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ADAG (Adagene)|IMA: Uzoq muddatli qarzning kapitalga nisbati|STTK (Shattuck Labs) - Uzoq muddatli qarzning o'z kapitaliga nisbati|EQ (Equillium Inc) - Uzoq muddatli qarzning kapitalga nisbati|Connect Pharma (CNTB) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunic, Inc. (IMUX)|ATRA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati InflaRx IFRX|Uzoq muddatli qarzdorlikning kapitalga nisbati X4 Pharmaceuticals Inc. (XFOR)|Adicet - Uzoq muddatli qarzning kapitalga nisbati|Celularity Inc. (CELU) - Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB: Uzoq muddatli qarzning kapitalga nisbati|BRNS - Uzoq muddatli qarzdorlikning kapitalga nisbati|KZR (Kezar Life Sciences, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati SAB Biotherapeutics Inc. SABS|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics plc (AKTX)|enlivex.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati QTTB (Q32 Bio)|GOVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Edesa Biotech - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati iBio Inc|carismatx.com (CARM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics Inc.|HCWB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati APVO|AIM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Aditxt, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|GRI Bio Corporation - Uzoq muddatli qarzning o'z kapitaliga nisbati|XORTX Therapeutics Inc. - Uzoq muddatli qarzning kapitalga nisbati|HIND: Uzoq muddatli qarzning o'z kapitaliga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SCNI (Scinai Immunotherapeutics Ltd)|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THRD: Uzoq muddatli qarzning kapitalga nisbati